Picture of Iterum Therapeutics logo

ITRMF — Iterum Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Brief: Iterum Therapeutics Reports Second Quarter 2021 Financial Results

Aug 13 (Reuters) - Iterum Therapeutics PLC  ITRM.O :
    * ITERUM THERAPEUTICS REPORTS SECOND QUARTER 2021 FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
    * ITERUM THERAPEUTICS PLC - QTRLY EARNINGS PER SHARE $0.04
    * ITERUM THERAPEUTICS PLC - QTRLY ADJUSTED LOSS PER SHARE
$0.04
    * ITERUM THERAPEUTICS PLC - AS OF JUNE 30, 2021, HAD CASH,
CASH
EQUIVALENTS AND SHORT-TERM INVESTMENTS OF $91.4 MILLION
    * ITERUM THERAPEUTICS PLC - EXPECTS CURRENT CASH, CASH
EQUIVALENTS, SHORT-TERM INVESTMENTS WILL BE SUFFICIENT TO FUND
ITS OPERATIONS INTO H2 2023

Source text for Eikon:  ID:nGNX8LkW0q 
Further company coverage:  ITRM.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Iterum Therapeutics

See all news